Kavuru Vimal
SEC CIK 1697184 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | Dir, 10% | 1.19M | $1.25M | — | 1 | 2023-09-25 | 2023-09-25 |
Most active insiders at GRCE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kohli Prashant | CEO, Dir | $214.0K | — |
| 2 | Opaleye Management Inc. | 10% | $87.8K | — |
Kavuru Vimal made no open-market trades at GRCE in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-09-27 | 2023-09-25 | GRCE | Grace Therapeutics, Inc. | Kavuru Vimal | Dir, 10% | P - Purchase | $1.85 | +676.4K | 1.19M | +132% | +$1.25M |
Purchase Sale Sale after option exercise All abbreviations